NCT02668081

Brief Summary

This study compares the effect of endoscopic sphincterotomy and endoscopic papillary balloon dilation in the treatment of acute biliary pancreatitis.Participants with acute biliary pancreatitis will be randomized into either the endoscopic sphincterotomy or endoscopic papillary balloon dilation groups.Moreover, the investigators compare the results obtained from the traditional bile/blood culture and metagenomics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

January 8, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 29, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

January 29, 2016

Status Verified

January 1, 2016

Enrollment Period

1.9 years

First QC Date

January 8, 2016

Last Update Submit

January 26, 2016

Conditions

Keywords

Endoscopic sphincterotomyEndoscopic papillary balloon dilationMetagenomics

Outcome Measures

Primary Outcomes (1)

  • Complete removal of common bile duct stones

    Successful bile duct clearance was defined as complete if the final cholangiogram revealed no more filling defects.

    one year

Secondary Outcomes (1)

  • Evaluation of adverse events

    One week

Study Arms (2)

Endoscopic papillary balloon dilation

EXPERIMENTAL

For EPBD group, after selective cannulation of the common bile duct by the catheter, cholangiography will be performed to confirm the diagnosis of bile duct pathology. A 0.025-0.035-inch guidewire will then be inserted into the bile duct through the catheter. A dilating balloon (The controlled radial expansion (CRE) balloon dilation catheter, CRE balloon 5.5 cm (centimeter) in length, 1-1.2 cm/1.2-1.5 cm/1.5-2.0 cm in diameter) will be passed via the pre-positioned guidewire into the bile duct. Using fluoroscopic and endoscopic guidance, the balloon will be inflated with contrast medium up to the optimal size and duration (normally 5min (minutes)) after the waist on the balloon disappeared according to the patients' condition and tolerance.

Procedure: Endoscopic papillary balloon dilation

Endoscopic sphincterotomy

ACTIVE COMPARATOR

For EST group,endoscopic sphincterotomy(EST) will be done as large as possible with a pull type sphincterotome (The TRUEtome, Biliary sphincterotomy sphincterotome, Single-use sphincterotome CleverCut2V) Other interventions: surgical intervention, endoscopic stenting, percutaneous transhepatic cholangiogram with balloon dilation

Procedure: Endoscopic sphincterotomy

Interventions

treatment of endoscopic papillary balloon dilation

Also known as: EPBD
Endoscopic papillary balloon dilation

treatment of endoscopic sphincterotomy

Also known as: EST
Endoscopic sphincterotomy

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with acute gallstone pancreatitis and fulfill any two items from a to c, plus one item in d, and e:
  • abdominal pain typical of pancreatitis;
  • elevation of serum amylase and/or lipase up to three times above normal;
  • imaging studies (abdominal ultrasound or abdominal computed tomography) showed evidence of pancreatitis
  • common bile duct stones, acute cholangitis (Charcot's triad), total bilirubin (total bilirubin)\> 4mg / dL, bile duct dilatation (diameter\> 6mm with intact gallbladder, or\> 10mm when the gallbladder has been removed) plus total bilirubin 1.8 \~ 4mg / dL;
  • exclude other causes of acute pancreatitis.

You may not qualify if:

  • septic shock
  • serious coagulopathy (international normalized ratio 1.5, partial thromboplastin time greater than twice that of control, platelet count \<50 x 1000 / Cumm)
  • malignant tumors of the biliary and pancreatic tract
  • severe cardiovascular or mental illness which can not cooperate with the exam and treatment;
  • pregnant women
  • patient who had ever received surgery or endoscopic treatment for biliopancreatic tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Veterans General Hospital.

Kaohsiung City, 386, Taiwan

RECRUITING

MeSH Terms

Interventions

Sphincterotomy, Endoscopic

Intervention Hierarchy (Ancestors)

Biliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeEndoscopy, GastrointestinalEndoscopy, Digestive SystemEndoscopyMinimally Invasive Surgical ProceduresSphincterotomyMyotomy

Study Officials

  • Hoi Hung Chan, MD, PhD

    Kaohsiung Veterans General Hospital.

    STUDY CHAIR

Central Study Contacts

Hoi Hung Chan, MD, PhD

CONTACT

Tzung Jiun Tsai, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

January 8, 2016

First Posted

January 29, 2016

Study Start

January 1, 2016

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

January 29, 2016

Record last verified: 2016-01

Locations